Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

Specialist researcher holding microscope slide analyzing blood sample working at coronavirus vaccine development during virus examination in microbiology hospital laboratory. Biochemistry experiment

Patients with inflammatory bowel diseases (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

The Gozney Dome is so much more than a pizza oven

Previous article

Save 67% on Kindle Unlimited this Black Friday

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News